Viking Therapeutics Statistics
Total Valuation
VKTX has a market cap or net worth of $3.42 billion. The enterprise value is $2.71 billion.
| Market Cap | 3.42B |
| Enterprise Value | 2.71B |
Important Dates
The last earnings date was Wednesday, October 28, 2026, after market close.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VKTX has 127.52 million shares outstanding. The number of shares has increased by 3.55% in one year.
| Current Share Class | 127.52M |
| Shares Outstanding | 127.52M |
| Shares Change (YoY) | +3.55% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 63.74% |
| Float | 124.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.33 |
| P/TBV Ratio | 5.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.27, with a Debt / Equity ratio of 0.43.
| Current Ratio | 7.27 |
| Quick Ratio | 7.17 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7,370.14 |
Financial Efficiency
Return on equity (ROE) is -96.37% and return on invested capital (ROIC) is -52.07%.
| Return on Equity (ROE) | -96.37% |
| Return on Assets (ROA) | -47.23% |
| Return on Invested Capital (ROIC) | -52.07% |
| Return on Capital Employed (ROCE) | -76.91% |
| Weighted Average Cost of Capital (WACC) | 7.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$8.48M |
| Employee Count | 74 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.55% in the last 52 weeks. The beta is 0.75, so VKTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -31.55% |
| 50-Day Moving Average | 29.17 |
| 200-Day Moving Average | 32.16 |
| Relative Strength Index (RSI) | 46.86 |
| Average Volume (20 Days) | 4,130,143 |
Short Selling Information
The latest short interest is 24.16 million, so 18.95% of the outstanding shares have been sold short.
| Short Interest | 24.16M |
| Short Previous Month | 25.54M |
| Short % of Shares Out | 18.95% |
| Short % of Float | 19.39% |
| Short Ratio (days to cover) | 4.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -648.57M |
| Pretax Income | -627.20M |
| Net Income | -627.20M |
| EBITDA | n/a |
| EBIT | -648.57M |
| Earnings Per Share (EPS) | -$5.41 |
Balance Sheet
The company has $959.81 million in cash and $254.69 million in debt, with a net cash position of $705.12 million or $5.53 per share.
| Cash & Cash Equivalents | 959.81M |
| Total Debt | 254.69M |
| Net Cash | 705.12M |
| Net Cash Per Share | $5.53 |
| Equity (Book Value) | 588.60M |
| Book Value Per Share | 4.62 |
| Working Capital | 839.10M |
Cash Flow
| Operating Cash Flow | -462.63M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 494,000 |
| Net Borrowing | 251.00M |
| Free Cash Flow | -462.63M |
| FCF Per Share | -$3.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.55% |
| Shareholder Yield | -3.55% |
| Earnings Yield | -20.19% |
| FCF Yield | -13.50% |
Analyst Forecast
The average price target for VKTX is $95.32, which is 255.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $95.32 |
| Price Target Difference | 255.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |